Biopharma Looks to the Netherlands as European Hub
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
Biopharma Looks to the Netherlands as European Hub
Biopharma Looks to the Netherlands as European Hub
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.